RadioMedix Inc. successfully completed the Phase I/ II clinical studies for AminoMedix ™ used for radiation kidney protection during Peptide-Receptor Radionuclide Therapy (PRRT)
October 20, 2016 02:30 ET
|
RadioMedix Inc.
Houston, TX, Oct. 20, 2016 (GLOBE NEWSWIRE) -- RadioMedix Inc. (Houston,TX) is excited to announce the completion of the Phase I/II clinical trial of AminoMedix ™ proprietary formulation used...
RadioMedix successful installations of SmartMedix and All in One (AIO) fully automated radiosynthesizers in USA.
September 12, 2016 06:00 ET
|
RadioMedix Inc.
Houston, TX, Sept. 12, 2016 (GLOBE NEWSWIRE) -- RadioMedix Inc. is pleased to announce successful installation of SmartMedix ™ (mini AIO) and All in One (AIO) synthesizers powered by Trasis S.A. for...
Viewpoint MT and RadioMedix secured a second SBIR NCI grant for image guided therapy of metastatic melanoma
August 27, 2015 00:00 ET
|
RadioMedix Inc.
Houston, TX, Aug. 27, 2015 (GLOBE NEWSWIRE) -- Viewpoint Molecular Targeting LLC.(Iowa City, IO) and RadioMedix Inc. (Houston TX) partnership resulted in the second Small Business Innovation...